key: cord-0772471-c4ah846d
authors: Subbian, Vignesh; Solomonides, Anthony; Clarkson, Melissa; Rahimzadeh, Vasiliki Nataly; Petersen, Carolyn; Schreiber, Richard; DeMuro, Paul R; Dua, Prerna; Goodman, Kenneth W; Kaplan, Bonnie; Koppel, Ross; Lehmann, Christoph U; Pan, Eric; Senathirajah, Yalini
title: Ethics and Informatics in the Age of COVID-19: Challenges and Recommendations for Public Health Organization and Public Policy
date: 2020-07-28
journal: J Am Med Inform Assoc
DOI: 10.1093/jamia/ocaa188
sha: c72d6ef3128c8708cdec61044ab264b3e7fd2f6a
doc_id: 772471
cord_uid: c4ah846d

The COVID-19 pandemic response in the United States has exposed significant gaps in information systems and processes to enable timely clinical and public health decision-making. Specifically, the use of informatics to mitigate the spread of SARS-CoV-2, support COVID-19 care delivery, and accelerate knowledge discovery bring to the forefront issues of privacy, surveillance, limits of state powers, and interoperability between public health and clinical information systems. Using a consensus building process, we critically analyze informatics-related ethical issues in light of the pandemic across three themes: (1) public health reporting and data sharing, (2) contact tracing and tracking, and (3) clinical scoring tools for critical care. We provide context and rationale for ethical considerations and recommendations that are actionable during the pandemic, and conclude with recommendations calling for long-term, broader change (beyond the pandemic) for public health organization and policy reform.

The United States was underprepared for the 2019 Novel Coronavirus Disease (COVID- 19) pandemic, despite experiencing recent outbreaks from the same virus family such as the 2003 severe acute respiratory syndrome (SARS) epidemic. [1] General warnings about and predictions of future pandemics and calls for global preparation [2] as well as specific early warnings [3] concerning the COVID-19 outbreak in Wuhan, China went unheeded. The responses from US public health agencies were generally disparate, uncoordinated, and inadequate to the challenge, resulting in insufficient supplies of protective equipment, a dearth of testing facilities and kits, and delays in test processing and results. Taken together, this lack of coordination made evident a fragmented information infrastructure that could not promptly and reliably provide even the most basic information related to daily case trends, hospital capacity, and healthcare supply chain. Various "social distancing" strategies and economic shutdowns across states curbed the initial spread of the virus in many parts of the country, but the rapid "reopening" in several areas -due to concerns about exacerbating the economic crisis and the public's desire to return to work and social activities-resulted in infection surges across communities. Emerging from the pandemic and preventing additional cycles of the disease will require advances in scientific understanding of SARS-CoV-2 and extensive public health resources, in addition to a vaccine.

These events provide informaticians with an opportunity to reflect on how to effect muchneeded changes in the US health system and the health information infrastructure and to inform public health policy with more reliable data and evidence. The biomedical informatics community, in collaboration with others, has a responsibility to assess the current information systems, regulations, and policies in responding to the pandemic and identify needed systemic changes. A substantial part of this assessment should address ethical, legal, and social issues that the SARS-CoV-2 outbreak brought to the fore. Consensus had been building prior to the pandemic that both privacy and research regulations were outdated and needed revisions to reflect technological changes, newer conceptions on privacy and bioethics, and the emerging view that expands health data to include many types of data collected by diverse entities, health related or otherwise. [4, 5] The pandemic has brought further scrutiny to previously identified complex ethical, political, and social issues. [6, 7] Building upon prior experiences and scholarship, we examine key informatics-related ethical issues in light of the COVID-19 pandemic and provide short-and longer-term recommendations for public health organization and policy.

The Ethical, Legal, and Social Issues (ELSI) Working Group of the American Medical Informatics Association (AMIA) has a long history of advocating for ethical and human-centered practices in applications of healthcare information technology. During April 2020, when the majority of US states had imposed stay-at-home orders or other activity restrictions, the ELSI working group launched a collaborative effort to identify and raise awareness about ethical issues that are crucial to the informatics community at large and to policy makers. The group identified three thematic areas of particular importance using a consensus building process (see Appendix A for details on methods): (1) public health reporting and data sharing, (2) contact tracing and tracking, and (3) clinical scoring tools. Although these themes intersect and have far-reaching implications at all levels of government and policy making, we consider issues related to public health reporting and data sharing to be centered at the national level (i.e., the need for rigorous coordination at the national level, while the actual data collection occurs locally), issues related to contract tracing and tracking to be centered at the community level, and those related to clinical scoring and assessment tools to be more relevant at the health system level. In the following sections, we lay out context and rationale for ELSI considerations, followed by recommendations that are actionable during the pandemic and recommendations that call for long-term, broader change (beyond the pandemic) for public health organization and policy (see Appendix A for a summary of recommendations). Other topics identified by the group (e.g., how the Health Insurance Portability and Accountability Act applies in light of were deemed outside the scope of this work as they warrant separate and more extensive analyses or were addressed elsewhere. [8] 

Public health responses should be premised on an evidence base which relies heavily on the collection, assessment, and dissemination of results from standardized public health reporting.

Critical data elements required for reporting include several domains such as 1) hospital capacity (e.g., number of intensive care unit beds and mechanical ventilators), 2) healthcare supply chains (e.g., inventory of personal protective equipment (PPE) and testing and ventilator supplies), 3) healthcare staffing needs (e.g., required number of respiratory therapists), and 4) demographic and outcome data on both presumptive and confirmed infections. Since the first confirmed case in the United States in late January 2020, the COVID-19 outbreak has exposed systemic vulnerabilities in the national public health reporting system that impeded timely evidence-based decision-making. These vulnerabilities stem in part from non-standardized, ad hoc reporting, [9, 10] as opposed to standardized, systematic, electronic reporting of data from state to federal agencies such as the Center for Disease Control and Prevention (CDC) and the Federal Emergency Management Agency (FEMA). Furthermore, the CDC's decision not to use the World Health Organization (WHO) COVID test but to develop its own, and the subsequent failure to deliver reliable results, initially resulted in delays of distributing approved testing kits.

This approach motivated local institutions to develop their own testing and reporting protocols, albeit with varying clinical validity and persistent delays in test results. To further exacerbate reporting issues, the Department of Health and Human Services (HHS) abruptly changed the process used by hospitals to submit daily COVID-19 reports about testing, hospitalizations, and hospital capacity in July 2020. Hospitals were instructed to submit data through a system developed by commercial contractor -TeleTracking Technologies Inc. Data will then be aggregated and analyzed using a new platform called HHS Protect built by another commercial entity -Palantir Technologies Inc., effectively bypassing the CDC. [11] [12] [13] [14] The stated purpose of this change was to streamline data collection and analysis, however it is as yet unclear whether and how aggregate trend data will be made publicly available. These events, together, highlight issues of not only efficiency and timeliness in obtaining and analyzing data, but also trust and transparency in how this data will inform policy responses as the pandemic evolves.

Disease surveillance efforts that report critical data elements (e.g., viral and antibody testing results, hospital capacity, PPEs, and healthcare staffing and supply needs) [15] should be consolidated, coordinated, and well-supported at local, state, and national levels. Current reporting standards are not robust enough, [16] and may lead local and state public health departments to take precaution-or fear-driven, rather than evidence-driven, action. In the aftermath of the 2014-2016 Ebola pandemic, for example, the CDC provided funding to develop PPE guidance and surveillance measures[17] that can be reliably integrated, interpreted, and used for modeling and decision-making. However, this ongoing effort was too late for deployment of nationwide standards. Researchers and journalists have also sought to compile their own COVID datasets in the absence of centralized efforts to track infections and supply shortages at local and regional levels. [18, 19] The principle of justice instills a responsibility to understand how COVID-19 may disproportionately impact some communities, workers, and demographic groups. Outbreaks among nursing home residents, prisoners, and low-wage workers in meat processing plants, [20] and higher rates of severe illness among racial and ethnic minority groups, [21] underscore the need to report data elements that make subgroup analysis possible. To better capture the social inequalities observed in COVID-19 patient outcomes, [22] public health reporting should include sociodemographic factors such as age, race, income (zip code or census tract level), gender, gender identity, ethnicity, disability status, and comorbidities in health outcome analyses. As of this writing (late July 2020), the CDC had released early reports on geographic and demographic differences and clinical outcomes among COVID-19 patients.[23-25] Although these results are useful, more nuanced and more rapid reporting is needed at local and state levels to direct public health resources to communities at greatest disease risk, and expose broader health disparities health that have long plagued the U.S. health services infrastructure.

Informed by this pandemic and prior AMIA work, [6, 7] we concluded that a more robust, standardized national reporting system is needed to effectively respond to future infectious disease outbreaks. A federal agency such as the CDC should be further empowered with coordinating data collection with local and state public health departments, and funded at a level that reflects the complexity and importance of this work. Major investments in building an informatics-based infrastructure are needed, as demonstrated by the continuing use of fax machines for case reporting to local health departments. Our call to modernize the infrastructure and process of disease surveillance is not new. The CDC's National Notifiable Diseases Surveillance System (NNDS) was launched in 2014, but results have fallen far short of the comprehensive change needed to efficiently and effectively conduct public health surveillance.

[26] Modernizing the public health reporting system will require 1) effective use of data standards, and interoperable systems that use those standards (e.g., LOINC codes established during the pandemic to identify laboratory tests for viral RNA or antibodies to the virus [27] ), 2) unique identifiers and metadata for testing facilities and tests, 3) robust management of the entire data pipeline from local to state to national public health agencies, and 4) abolishment of paper-based systems and authentic collaboration with and support from electronic health record (EHR) vendors and the standards community to build and maintain the necessary technical infrastructure to automatically collect and report critical data elements.

One of the major pandemic mitigation strategies promoted by WHO has been summarized as Trace, Test, and Treat [28] , which stands for identifying new cases, tracing their social contacts, and then testing and treating them. Given the inadequate response to measures intended to limit the spread of the virus and avert a worsening economic crisis, the US is contemplating a "tracking" strategy rather than contact tracing. Trace and Track seem similar at first glance, but there is a difference between contacting an infected person and asking them (voluntarily) for their contacts, who then in turn can be alerted, versus an automated and potentially covert system that tracks the general public and may lack transparency.

Automated tracking raises ethical concerns related to privacy and control of personal devices. Countries such as Taiwan have shown that geo-tracking using mobile phones can be used not only to enable contact tracing, but also to ensure that citizens are complying with selfquarantine orders. [29] Such constant data collection and analysis through mobile applications is highly intrusive and is prone to abuse when the data are sold or reused for commercial purposes, such as in advertising, targeted marketing, or employment and credit decisions.

Tracking puts privacy and autonomy at risk and may endanger safety, including financial security, especially when data are used by banking or billing apps.

In the context of tracking during this crisis, we assert that all collected data have implications to health insofar as a trip to the grocery store or gas station, a jog in the park, or a take-away food order all contribute to an individual's potential exposure to SARS-CoV-2. With certain coordinates, the collected geodata can identify an individual. The majority of mobile apps do not specify how long their data collections will persist nor whether the collected data will be purged. The extent of such (ab)use of collected data, sometimes deprecated as "digital or data exhaust", has been exposed by both scholars and journalists, [30] but is still not widely known to the public.

Few privacy-preserving methods and tools exist to support benign contact tracing. Such tracing does not identify persons to others, but rather notifies exposed persons directly about when and where they may have been exposed.[31,32] These methods are more reliable because information is retained on the user's phone while only general geolocation details, such as a visit to a specific location, are known to the developer or vendors. It is important to leverage such techniques and use the least intrusive technology and collect the minimally required data for tracking. If tracking must be based on a particular technology, the choice should be justified by providing integral privacy protections to safeguard the data from unintended or undisclosed use and to ease concern about surveillance. With resurgence of infections throughout the country and mounting determination to "flatten the curve", it may be ethically defensible to heighten tracking as a way to enhance safeguards during public health emergencies. However, the long-term risks to privacy and the potential repurposing of collected information remain problematic. Balancing the use of data and technology for public good versus protection of privacy is key. Laws and/or regulations might be enacted and/or amended as necessary to prevent COVID-19 data from being exploited, whether by governments or commercial entities. Such amendments may include mandating complete transparency about what data are being used and how, in both short-and long-term.

Location and contact tracing illustrate how all data can function as health data, which then implies that all personal data should receive the same protection as health data. Both Given some relaxation in HIPAA enforcement (e.g., for telehealth providers and in using/disclosing protected health information related to substance abuse to authorized personnel) due to the public health emergency, discussion of HIPAA and other privacy reform should continue at the national level. This is an excellent opportunity for the US to consider harmonizing the patchwork of sector-based privacy regulations to enable a more uniform and responsive set of protections nationwide, along with significant attention to improved cybersecurity. 

EHR vendors are rapidly building and deploying features to collect underlying clinical data needed for the score, compute the severity score, and repeat measurements as appropriate, though not all institutions have enabled such features. It is important to ensure that computerized versions of clinical scores are well-calibrated and used as intended in crisis standard-of-care guidelines. Scoring tools should not be used for purposes for which they were not designed. For example, the original SOFA score should be repeatedly assessed to evaluate the severity of the disease and the duration of ICU resource needs, [35] but has not been validated for predicting the risk of mortality. Should there be shortages of ICU beds and ventilators due to the crisis, clinicians and triage panels need to be able to reliably use the scores to allocate resources. Second, EHR implementations of clinical scores should be adaptive to local circumstances and to emerging observations and evidence from pandemic investigations. For instance, early studies suggest that not many COVID-19 patients go into respiratory failure earlier than organ dysfunction, [36] which makes the use of SOFA as a part of standard of care less appropriate.

The pandemic postdrome is an unparalleled opportunity to study, critique, and improve crisis standard-of-care guidelines and tools. First, there needs to be a robust, retrospective evaluation of the specific scoring tools used for triage and resource allocation, which often include assessment of COVID-19 severity, possible need for critical care, and likelihood of interventions such as intubation. Second, local conditions, patient preferences, and continuous monitoring and availability of critical resources must be considered. Some patients may not want measures such as ventilator care. If resources or treatment options that were previously unavailable (e.g., extracorporeal membrane oxygenation) now become available, re-assessment of decisions are needed. Algorithms and clinical scores rarely include these data. If scoring tools are used for ICU admission triage and allocation of resources, they may well need reengineering to incorporate patient preferences, resource availability, and other aspects that are not now considered. Third, healthcare organizations and public health agencies should develop future crisis standards in consultation with key stakeholders and community groups. For instance, a number of disability rights organizations have faulted COVID-19 treatment guides as embedding discrimination against people with disabilities, in part because of the use of comorbidities as a way to fine-tune SOFA scores. Although these concerns were adequately addressed in some jurisdictions, more work is needed to build and sustain trust in vulnerable populations.

By early April 2020, the United States reported the world's highest incidence of, prevalence of, and mortality from COVID-19. Gross shortages in medical supplies at the point of care, rapid community transmission, insufficient testing capacity, and ultimately, increasing incidence and mortality have come to define the national emergency in the United States thus far. Underlying issues include the lack of a standardized, nationally-coordinated reporting system for critical data elements, lack of trustworthy and accountable ways to deploy technological solutions for contact tracing, and lack of well-calibrated algorithms that can be used in standards-of-care applicable during a crisis. This work introduces each of these issues, along with short-and longer-term recommendations to guide future public health and institutional policies and practices. Having a sound ethics-based rationale and transparent approach for responses to severe public health threats can lead to better public acceptance, harmonized and strengthened standards across different domains related to data and information technologies, and increased public trust in governmental and commercial entities for routine as well as crisis practice. In addition to the longer-term recommendations described in this perspective, future work at the intersection of ELSI and informatics will include a stronger focus on (a) regulatory waivers and potential policy reform as it relates to Table A1 ) which involved controversial elements at the intersection of ethics and informatics as the pandemic evolved. The following topics were thought to be beyond the scope of this work either because there was no strong informatics role at play or the issue was already addressed elsewhere:

 Antimicrobial stewardship programs and antimicrobial resistance [1]  Ethics of health worker protection and freedom to speak [2]  HIPAA waivers and health information exchange [3]  Health disparities and COVID-19 [4] https://mc.manuscriptcentral.com/jamia  Telemedicine and End-User License Agreements at the Point-of-Care  Political issues related to pandemic response in the U.S.

It is noteworthy that the author team brought a variety of perspectives and experiences to the ethical analysis of topics presented in this work. In addition to ethicists and legal experts, the team included practicing clinical and research informaticians, advocates for patients and patient safety, clinicians, and informatics researchers. The project, however, was limited in terms of public health expertise and direct experience from COVID-19 patients. 

surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases--United States and worldwide

Two years after pandemic influenza A/2009/H1N1: What have we learned?

HIPAA and protecting health information in the 21st Century

Trust Framework and Code of Conduct -CARIN Alliance

A National Agenda for Public Health Informatics: Summarized Recommendations from the 2001 AMIA Spring Congress

Toward a National Framework for the Secondary Use of Health Data: An American Medical Informatics Association White

Balancing health privacy, health information exchange, and research in the context of the COVID-19 pandemic

COVID-19 Module | NHSN | CDC

Information for Health Departments on Reporting Cases of COVID-19 | CDC

COVID-19 Guidance for Hospital Reporting and FAQs For Hospitals, Hospital Laboratory, and Acute Care Facility Data Reporting

Prepared Remarks from HHS Media Call with CDC Director Redfield and CIO Arrieta on COVID-19 Data Collection

Data secrecy is crippling attempts to slow COVID-19's spread in U.S., epidemiologists warn. Science (80-) Published Online First: 16

An Open Letter from the American Medical Informatics Association and the American College of Medical Informatics Regarding Public Health Reporting Deficiencies During the

Respirator Use in a Hospital Setting: Establishing Surveillance Metrics

Rapid Expert Consultation on Data Elements and Systems Design for Modeling and Decision Making for the COVID-19 Pandemic

Ebola Response Supplemental Funding: PHEP Supplemental Funding for Ebola Preparedness and Response Activities

COVID-19 Map -Johns Hopkins Coronavirus Resource Center

Tackle coronavirus in vulnerable communities

COVID-19 and Racial/Ethnic Disparities

Failing Another National Stress Test on Health

Published Online First: 15

Geographic Differences in COVID-19 Cases, Deaths, and Incidence -United States

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease

Race/Ethnicity, Underlying Medical Conditions, Homelessness, and Hospitalization Status of Adult Patients with COVID-19 at an Urban Safety-Net Medical Center

How to Report COVID-19 Laboratory Data

World Health Organization

Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing

Big other: Surveillance capitalism and the prospects of an information civilization

Privacy-Preserving Proximity Tracking

Privacy Preserving Techniques Handbook UN Global Platform

Utah Crisis Standards of Care Guidelines

Engineering and M. Rapid Expert Consultation on Crisis Standards of Care for the COVID-19 Pandemic

Definitive care for the critically III during a disaster: A framework for allocation of scarce resources in mass critical care

Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations

The Ethical Significance of Antimicrobial Resistance

Health and care workers should be free to speak out on PPE

Balancing health privacy, health information exchange, and research in the context of the COVID-19 pandemic

COVID-19 and Racial/Ethnic Disparities